Fig. 3.

Adjusted change in back pain from baseline: 100 mm VAS. Model includes back pain VAS baseline value, age, duration of prior bisphosphonate therapy, rheumatoid arthritis, and history of fracture in the 12 months prior to starting teriparatide therapy. All values: P < 0.001 compared to baseline. Actual unadjusted values of mean (SD) at 0, 3, 6, 12, and 18 months were 57.7 (26.6), 42.8 (25.1), 38.2 (25.4), 34.6 (25.7), and 31.6 (25.6) mm, respectively